Kyle Faget has joined Foley & Lardner LLP’s Government & Public Policy Practice Group as special counsel in the Boston office. She has also joined the firm’s Health Care and Life Sciences Industry Teams.
A seasoned attorney with close to ten years of regulatory and compliance experience, Faget has worked both as an in-house counsel and for a national law firm serving clients in the corporate and government enforcement litigation spaces. Her work has included both managing and advising clients on matters involving pharmaceutical and medical device product promotion issues; sales force compliance training; corporate integrity agreement and deferred prosecution agreement implementation and compliance, including representing a company’s clinical trial program in its annual Independent Review Organization audit and corresponding corrective action plan drafting and implementation; and assessing health care provider grants and charitable donations. In addition, Faget has managed government enforcement cases and internal investigations involving kickback violations and Medicare/Medicaid billing/reimbursement issues, and she has also rendered opinions regarding orphan drug applications in the U.S. and U.K.
Faget also has experience with drafting and negotiating health care professional consulting agreements, clinical trial agreements, informed consents, investigator-initiated study agreements, collaboration agreements, manufacturing agreements, material transfer agreements and non-disclosure agreements.
Prior to joining Foley, Faget served as senior counsel at Jounce Therapeutics. She earned her J.D. at the University of Michigan Law School.
A seasoned attorney with close to ten years of regulatory and compliance experience, Faget has worked both as an in-house counsel and for a national law firm serving clients in the corporate and government enforcement litigation spaces. Her work has included both managing and advising clients on matters involving pharmaceutical and medical device product promotion issues; sales force compliance training; corporate integrity agreement and deferred prosecution agreement implementation and compliance, including representing a company’s clinical trial program in its annual Independent Review Organization audit and corresponding corrective action plan drafting and implementation; and assessing health care provider grants and charitable donations. In addition, Faget has managed government enforcement cases and internal investigations involving kickback violations and Medicare/Medicaid billing/reimbursement issues, and she has also rendered opinions regarding orphan drug applications in the U.S. and U.K.
Faget also has experience with drafting and negotiating health care professional consulting agreements, clinical trial agreements, informed consents, investigator-initiated study agreements, collaboration agreements, manufacturing agreements, material transfer agreements and non-disclosure agreements.
Prior to joining Foley, Faget served as senior counsel at Jounce Therapeutics. She earned her J.D. at the University of Michigan Law School.
People
Related News
December 10, 2025
Press Releases
Foley Chairman and CEO Daljit Doogal Reelected to Second Term
Foley & Lardner LLP is pleased to announce that Daljit Doogal has been reelected to serve as Chairman and CEO for a second, four-year term beginning May 1, 2026, upon expiration of his current term, and effective through April 30, 2030.
November 18, 2025
Press Releases
Foley Announces Joe Dowdy as Raleigh Office Managing Partner
Foley & Lardner LLP has appointed litigator Joseph Dowdy as managing partner of the firm’s Raleigh, North Carolina, office.
October 20, 2025
Press Releases
Foley Welcomes 2025 New Associate Class
Foley & Lardner LLP welcomes its 2025 associate class—69 new lawyers and clerks across 18 offices and 16 practice areas—highlighting the firm’s nationwide commitment to top legal talent, professional development, and client service excellence.